PAH News

January 13, 2020January 13, 2020

Orenitram Slows PAH Progression When Used With Other Therapies, Phase 3 Trial Finds

News, PAH News

Orenitram (treprostinil tablets) reduced clinical worsening and slowed disease progression in people with pulmonary arterial hypertension (PAH) who had recently begun treatment with an alternative approved therapy, a Phase ... Read more

January 10, 2020January 10, 2020

AI Therapeutics Seeks Partner to Advance Testing of LAM-001, its Candidate Inhaled Therapy for PAH

News, PAH News

AI Therapeutics is seeking to advance the development of its candidate treatment LAM-001 for patients with lymphangioleiomyomatosis (LAM) and pulmonary arterial hypertension (PAH), two rare lung disorders. Specifically, the ... Read more

January 6, 2020January 6, 2020

Acceleron Pharma and Fulcrum Therapeutics Partner to Find Small Molecule Treatments

News, PAH News, PH News

Acceleron Pharma and Fulcrum Therapeutics are working together to discover small molecules that can be used to treat pulmonary diseases, including pulmonary hypertension (PH). Under this collaboration, Acceleron will ... Read more

January 3, 2020January 3, 2020

Oral Melatonin Seen to Protect Against Signs and Symptoms of PAH, Study in Mice Reports

News, PAH News

Melatonin, a natural hormone involved in sleep and believed to protect against cardiovascular diseases, may help to relieve the signs and symptoms of pulmonary arterial hypertension (PAH), an early ... Read more

December 13, 2019December 13, 2019

Bioelectronic Medicine May Open New Therapeutic Avenues for PAH, Review Says

News, PAH News

Bioelectronic medicine is a promising new therapeutic approach to treat pulmonary arterial hypertension (PAH), according to a recent review study. The review, “Pulmonary arterial hypertension: the case for a ... Read more

December 9, 2019December 9, 2019

TriAxia Health Partners with Major Medical Centers to Build PAH Research Database

News, PAH News

TriAxia Health is partnering with three academic medical centers to build a large database aiming for a better understanding of rare pulmonary diseases, beginning with pulmonary arterial hypertension (PAH). ... Read more

December 2, 2019December 2, 2019

Study Suggests CPET as Way to Identify PAH in Systemic Sclerosis Patients

News, PAH News

Cardiopulmonary exercise testing can improve the ability of an algorithm to identify systemic sclerosis patients who have pulmonary arterial hypertension (PAH), a new study suggests. The study, “Cardiopulmonary exercise ... Read more

November 20, 2019November 20, 2019

Antibody Able to Block Protein That Promotes PAH and May Bolster Existing Therapies, Study Finds

News, PAH News

An antibody that recognizes and blocks the activity of osteoprotegerin, a protein involved in the development of pulmonary arterial hypertension (PAH), was able to stop and even reverse disease ... Read more

October 25, 2019October 25, 2019

Rodatristat Ethyl May Reduce Serotonin Production and Affect Vascular Remodeling in PAH Patients, Study Suggests

News, PAH News

Oral treatment with rodatristat ethyl is safe and reduced the levels of serotonin — a hormone whose high levels may promote the tightening of pulmonary artery muscle cells — ... Read more

PAH News

Orenitram Slows PAH Progression When Used With Other Therapies, Phase 3 Trial Finds

AI Therapeutics Seeks Partner to Advance Testing of LAM-001, its Candidate Inhaled Therapy for PAH

Acceleron Pharma and Fulcrum Therapeutics Partner to Find Small Molecule Treatments

Top 10 Pulmonary Hypertension Stories of 2019

Oral Melatonin Seen to Protect Against Signs and Symptoms of PAH, Study in Mice Reports

Bioelectronic Medicine May Open New Therapeutic Avenues for PAH, Review Says

TriAxia Health Partners with Major Medical Centers to Build PAH Research Database

Study Suggests CPET as Way to Identify PAH in Systemic Sclerosis Patients

Antibody Able to Block Protein That Promotes PAH and May Bolster Existing Therapies, Study Finds

Rodatristat Ethyl May Reduce Serotonin Production and Affect Vascular Remodeling in PAH Patients, Study Suggests

Pin It on Pinterest